APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Ponatinib Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Ponatinib Drugs Industry Growth and Trends Forecast to 2032

Report ID 174027250122 December 202576 pages

Choose your research edition.

Industry ResearchPonatinib Drugs Industry Research Report 2026111 pages · $2,950 USDIndustry Growth & TrendsGlobal Ponatinib Drugs Industry Growth and Trends Forecast to 203276 pages · $3,450 USDMarket StructureGlobal Ponatinib Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032175 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Ponatinib Drugs Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Ponatinib Drugs Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Ponatinib Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Ponatinib Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Ponatinib Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Ponatinib Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Ponatinib Drugs include ARIAD Pharmaceuticals. among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Ponatinib Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Ponatinib Drugs market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Ponatinib Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Ponatinib Drugs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Ponatinib Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Ponatinib Drugs Market by Company

ARIAD Pharmaceuticals

Ponatinib Drugs Segment by Type

15mg

45mg

Ponatinib Drugs Segment by Application

CML

ALL

Ponatinib Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ponatinib Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Ponatinib Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ponatinib Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Ponatinib Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Ponatinib Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 15mg Table 2. Major Company of 45mg Table 3. Global Ponatinib Drugs Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Ponatinib Drugs Sales by Type (2021-2026) & (k units) Table 5. Global Ponatinib Drugs Sales Market Share in Volume by Type (2021-2026) Table 6. Global Ponatinib Drugs Sales by Type (2021-2026) & (US$ Million) Table 7. Global Ponatinib Drugs Sales Market Share in Value by Type (2021-2026) Table 8. Global Ponatinib Drugs Price by Type (2021-2026) & (US$/unit) Table 9. Global Ponatinib Drugs Sales by Type (2027-2032) & (k units) Table 10. Global Ponatinib Drugs Sales Market Share in Volume by Type (2027-2032) Table 11. Global Ponatinib Drugs Sales by Type (2027-2032) & (US$ Million) Table 12. Global Ponatinib Drugs Sales Market Share in Value by Type (2027-2032) Table 13. Global Ponatinib Drugs Price by Type (2027-2032) & (US$/unit) Table 14. North America Ponatinib Drugs Sales by Type (2021-2026) & (k units) Table 15. North America Ponatinib Drugs Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Ponatinib Drugs Sales by Type (2021-2026) & (k units) Table 17. Europe Ponatinib Drugs Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Ponatinib Drugs Sales by Type (2021-2026) & (k units) Table 19. Asia-Pacific Ponatinib Drugs Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Ponatinib Drugs Sales by Type (2021-2026) & (k units) Table 21. Latin America Ponatinib Drugs Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Ponatinib Drugs Sales by Type (2021-2026) & (k units) Table 23. Middle East and Africa Ponatinib Drugs Sales by Type (2021-2026) & (US$ Million) Table 24. Ponatinib Drugs Industry Trends Table 25. Ponatinib Drugs Industry Drivers Table 26. Ponatinib Drugs Industry Opportunities and Challenges Table 27. Ponatinib Drugs Industry Restraints Table 28. Global Ponatinib Drugs Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Ponatinib Drugs Revenue Market Share by Company (2021-2026) Table 30. Global Ponatinib Drugs Sales by Company (2021-2026) & (k units) Table 31. Global Ponatinib Drugs Sales Share by Company (2021-2026) Table 32. Global Ponatinib Drugs Market Price by Company (2021-2026) & (US$/unit) Table 33. Global Ponatinib Drugs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Ponatinib Drugs Major Company Production Sites and Headquarters Table 35. Global Ponatinib Drugs Company, Product Type & Application Table 36. Global Ponatinib Drugs Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Ponatinib Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Ponatinib Drugs Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Ponatinib Drugs Sales by Region (2021-2026) & (k units) Table 41. Global Ponatinib Drugs Sales Market Share in Volume by Region (2021-2026) Table 42. Global Ponatinib Drugs Sales by Region (2021-2026) & (US$ Million) Table 43. Global Ponatinib Drugs Sales Market Share in Value by Region (2021-2026) Table 44. Global Ponatinib Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 45. Global Ponatinib Drugs Sales by Region (2027-2032) & (k units) Table 46. Global Ponatinib Drugs Sales Market Share in Volume by Region (2027-2032) Table 47. Global Ponatinib Drugs Sales by Region (2027-2032) & (US$ Million) Table 48. Global Ponatinib Drugs Sales Market Share in Value by Region (2027-2032) Table 49. Global Ponatinib Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 50. Global Ponatinib Drugs Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Ponatinib Drugs Sales by Application (2021-2026) & (k units) Table 52. Global Ponatinib Drugs Sales Market Share in Volume by Application (2021-2026) Table 53. Global Ponatinib Drugs Sales by Application (2021-2026) & (US$ Million) Table 54. Global Ponatinib Drugs Sales Market Share in Value by Application (2021-2026) Table 55. Global Ponatinib Drugs Price by Application (2021-2026) & (US$/unit) Table 56. Global Ponatinib Drugs Sales by Application (2027-2032) & (k units) Table 57. Global Ponatinib Drugs Sales Market Share in Volume by Application (2027-2032) Table 58. Global Ponatinib Drugs Sales by Application (2027-2032) & (US$ Million) Table 59. Global Ponatinib Drugs Sales Market Share in Value by Application (2027-2032) Table 60. Global Ponatinib Drugs Price by Application (2027-2032) & (US$/unit) Table 61. North America Ponatinib Drugs Sales by Application (2021-2026) & (k units) Table 62. North America Ponatinib Drugs Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Ponatinib Drugs Sales by Application (2021-2026) & (k units) Table 64. Europe Ponatinib Drugs Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Ponatinib Drugs Sales by Application (2021-2026) & (k units) Table 66. Asia-Pacific Ponatinib Drugs Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Ponatinib Drugs Sales by Application (2021-2026) & (k units) Table 68. Latin America Ponatinib Drugs Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Ponatinib Drugs Sales by Application (2021-2026) & (k units) Table 70. Middle East and Africa Ponatinib Drugs Sales by Application (2021-2026) & (US$ Million) Table 71. ARIAD Pharmaceuticals Company Information Table 72. ARIAD Pharmaceuticals Business Overview Table 73. ARIAD Pharmaceuticals Ponatinib Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. ARIAD Pharmaceuticals Ponatinib Drugs Product Portfolio Table 75. ARIAD Pharmaceuticals Recent Development Table 76. North America Ponatinib Drugs Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 77. North America Ponatinib Drugs Sales by Country (2021-2026) & (k units) Table 78. North America Ponatinib Drugs Sales Market Share by Country (2021-2026) Table 79. North America Ponatinib Drugs Sales Forecast by Country (2027-2032) & (k units) Table 80. North America Ponatinib Drugs Sales Market Share Forecast by Country (2027-2032) Table 81. North America Ponatinib Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 82. North America Ponatinib Drugs Market Size by Country (2021-2026) & (US$ Million) Table 83. North America Ponatinib Drugs Market Share by Country (2021-2026) Table 84. North America Ponatinib Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 85. North America Ponatinib Drugs Market Share Forecast by Country (2027-2032) Table 86. Europe Ponatinib Drugs Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 87. Europe Ponatinib Drugs Sales by Country (2021-2026) & (k units) Table 88. Europe Ponatinib Drugs Sales Market Share by Country (2021-2026) Table 89. Europe Ponatinib Drugs Sales Forecast by Country (2027-2032) & (k units) Table 90. Europe Ponatinib Drugs Sales Market Share Forecast by Country (2027-2032) Table 91. Europe Ponatinib Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 92. Europe Ponatinib Drugs Market Size by Country (2021-2026) & (US$ Million) Table 93. Europe Ponatinib Drugs Market Share by Country (2021-2026) Table 94. Europe Ponatinib Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 95. Europe Ponatinib Drugs Market Share Forecast by Country (2027-2032) Table 96. Asia-Pacific Ponatinib Drugs Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 97. Asia-Pacific Ponatinib Drugs Sales by Country (2021-2026) & (k units) Table 98. Asia-Pacific Ponatinib Drugs Sales Market Share by Country (2021-2026) Table 99. Asia-Pacific Ponatinib Drugs Sales Forecast by Country (2027-2032) & (k units) Table 100. Asia-Pacific Ponatinib Drugs Sales Market Share Forecast by Country (2027-2032) Table 101. Asia-Pacific Ponatinib Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 102. Asia-Pacific Ponatinib Drugs Market Size by Country (2021-2026) & (US$ Million) Table 103. Asia-Pacific Ponatinib Drugs Market Share by Country (2021-2026) Table 104. Asia-Pacific Ponatinib Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 105. Asia-Pacific Ponatinib Drugs Market Share Forecast by Country (2027-2032) Table 106. Latin America Ponatinib Drugs Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 107. Latin America Ponatinib Drugs Sales by Country (2021-2026) & (k units) Table 108. Latin America Ponatinib Drugs Sales Market Share by Country (2021-2026) Table 109. Latin America Ponatinib Drugs Sales Forecast by Country (2027-2032) & (k units) Table 110. Latin America Ponatinib Drugs Sales Market Share Forecast by Country (2027-2032) Table 111. Latin America Ponatinib Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 112. Latin America Ponatinib Drugs Market Size by Country (2021-2026) & (US$ Million) Table 113. Latin America Ponatinib Drugs Market Share by Country (2021-2026) Table 114. Latin America Ponatinib Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 115. Latin America Ponatinib Drugs Market Share Forecast by Country (2027-2032) Table 116. Middle East and Africa Ponatinib Drugs Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 117. Middle East and Africa Ponatinib Drugs Sales by Country (2021-2026) & (k units) Table 118. Middle East and Africa Ponatinib Drugs Sales Market Share by Country (2021-2026) Table 119. Middle East and Africa Ponatinib Drugs Sales Forecast by Country (2027-2032) & (k units) Table 120. Middle East and Africa Ponatinib Drugs Sales Market Share Forecast by Country (2027-2032) Table 121. Middle East and Africa Ponatinib Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 122. Middle East and Africa Ponatinib Drugs Market Size by Country (2021-2026) & (US$ Million) Table 123. Middle East and Africa Ponatinib Drugs Market Share by Country (2021-2026) Table 124. Middle East and Africa Ponatinib Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 125. Middle East and Africa Ponatinib Drugs Market Share Forecast by Country (2027-2032) Table 126. Key Raw Materials Table 127. Raw Materials Key Suppliers Table 128. Ponatinib Drugs Distributors List Table 129. Ponatinib Drugs Customers List Table 130. Research Programs/Design for This Report Table 131. Authors List of This Report Table 132. Secondary Sources Table 133. Primary Sources List of Figures Figure 1. Ponatinib Drugs Image Figure 2. Global Ponatinib Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Ponatinib Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Ponatinib Drugs Sales (2021-2032) & (k units) Figure 5. 15mg Image Figure 6. Global 15mg Sales YoY Growth (2021-2032) & (k units) Figure 7. 45mg Image Figure 8. Global 45mg Sales YoY Growth (2021-2032) & (k units) Figure 9. Global Ponatinib Drugs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Ponatinib Drugs Market Share by Type 2025 VS 2032 Figure 11. North America Ponatinib Drugs Sales Market Share in Volume by Type in 2025 Figure 12. North America Ponatinib Drugs Sales Market Share in Value by Type in 2025 Figure 13. Europe Ponatinib Drugs Sales Market Share in Volume by Type in 2025 Figure 14. Europe Ponatinib Drugs Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Ponatinib Drugs Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Ponatinib Drugs Sales Market Share in Value by Type in 2025 Figure 17. Latin America Ponatinib Drugs Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Ponatinib Drugs Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Ponatinib Drugs Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Ponatinib Drugs Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Ponatinib Drugs Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. CML Image Figure 24. Global CML Sales YoY Growth (2021-2032) & (k units) Figure 25. ALL Image Figure 26. Global ALL Sales YoY Growth (2021-2032) & (k units) Figure 27. Global Ponatinib Drugs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Ponatinib Drugs Market Share by Application 2025 VS 2032 Figure 29. North America Ponatinib Drugs Sales Market Share in Volume by Application in 2025 Figure 30. North America Ponatinib Drugs Sales Market Share in Value by Application in 2025 Figure 31. Europe Ponatinib Drugs Sales Market Share in Volume by Application in 2025 Figure 32. Europe Ponatinib Drugs Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Ponatinib Drugs Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Ponatinib Drugs Sales Market Share in Value by Application in 2025 Figure 35. Latin America Ponatinib Drugs Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Ponatinib Drugs Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Ponatinib Drugs Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Ponatinib Drugs Sales Market Share in Value by Application in 2025 Figure 39. North America Ponatinib Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 40. North America Ponatinib Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Ponatinib Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Ponatinib Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Ponatinib Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 44. Europe Ponatinib Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Ponatinib Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Ponatinib Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Ponatinib Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 48. Asia-Pacific Ponatinib Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Ponatinib Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Ponatinib Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Ponatinib Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 52. Latin America Ponatinib Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Ponatinib Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Ponatinib Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Ponatinib Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 56. Middle East and Africa Ponatinib Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Ponatinib Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Ponatinib Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Ponatinib Drugs Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Ponatinib Drugs Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • 15mg
  • 45mg
Applications
  • CML
  • ALL
Companies covered
  • ARIAD Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Ponatinib Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Ponatinib Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Ponatinib Drugs Market by Type
  6. 1.3.1 15mg
  7. 1.3.2 45mg
  8. 1.4 Global Ponatinib Drugs Market Size by Type
  9. 1.4.1 Global Ponatinib Drugs Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Ponatinib Drugs Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Ponatinib Drugs Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Ponatinib Drugs Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Ponatinib Drugs Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Ponatinib Drugs Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Ponatinib Drugs Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Ponatinib Drugs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Ponatinib Drugs Industry Trends
  2. 2.2 Ponatinib Drugs Industry Drivers
  3. 2.3 Ponatinib Drugs Industry Opportunities and Challenges
  4. 2.4 Ponatinib Drugs Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Ponatinib Drugs Revenue (2021-2026)
  2. 3.2 Global Top Players by Ponatinib Drugs Sales (2021-2026)
  3. 3.3 Global Top Players by Ponatinib Drugs Price (2021-2026)
  4. 3.4 Global Ponatinib Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Ponatinib Drugs Major Company Production Sites & Headquarters
  6. 3.6 Global Ponatinib Drugs Company, Product Type & Application
  7. 3.7 Global Ponatinib Drugs Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Ponatinib Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Ponatinib Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Ponatinib Drugs Tier 1, Tier 2, and Tier 3
4 Ponatinib Drugs Regional Status and Outlook
  1. 4.1 Global Ponatinib Drugs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Ponatinib Drugs Historic Market Size by Region
  3. 4.2.1 Global Ponatinib Drugs Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Ponatinib Drugs Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Ponatinib Drugs Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Ponatinib Drugs Forecasted Market Size by Region
  7. 4.3.1 Global Ponatinib Drugs Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Ponatinib Drugs Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Ponatinib Drugs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Ponatinib Drugs by Application
  1. 5.1 Ponatinib Drugs Market by Application
  2. 5.1.1 CML
  3. 5.1.2 ALL
  4. 5.2 Global Ponatinib Drugs Market Size by Application
  5. 5.2.1 Global Ponatinib Drugs Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Ponatinib Drugs Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Ponatinib Drugs Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Ponatinib Drugs Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Ponatinib Drugs Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Ponatinib Drugs Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Ponatinib Drugs Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Ponatinib Drugs Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 ARIAD Pharmaceuticals
  2. 6.1.1 ARIAD Pharmaceuticals Company Information
  3. 6.1.2 ARIAD Pharmaceuticals Business Overview
  4. 6.1.3 ARIAD Pharmaceuticals Ponatinib Drugs Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 ARIAD Pharmaceuticals Ponatinib Drugs Product Portfolio
  6. 6.1.5 ARIAD Pharmaceuticals Recent Developments
7 North America by Country
  1. 7.1 North America Ponatinib Drugs Sales by Country
  2. 7.1.1 North America Ponatinib Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Ponatinib Drugs Sales by Country (2021-2026)
  4. 7.1.3 North America Ponatinib Drugs Sales Forecast by Country (2027-2032)
  5. 7.2 North America Ponatinib Drugs Market Size by Country
  6. 7.2.1 North America Ponatinib Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Ponatinib Drugs Market Size by Country (2021-2026)
  8. 7.2.3 North America Ponatinib Drugs Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Ponatinib Drugs Sales by Country
  2. 8.1.1 Europe Ponatinib Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Ponatinib Drugs Sales by Country (2021-2026)
  4. 8.1.3 Europe Ponatinib Drugs Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Ponatinib Drugs Market Size by Country
  6. 8.2.1 Europe Ponatinib Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Ponatinib Drugs Market Size by Country (2021-2026)
  8. 8.2.3 Europe Ponatinib Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Ponatinib Drugs Sales by Country
  2. 9.1.1 Asia-Pacific Ponatinib Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Ponatinib Drugs Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Ponatinib Drugs Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Ponatinib Drugs Market Size by Country
  6. 9.2.1 Asia-Pacific Ponatinib Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Ponatinib Drugs Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Ponatinib Drugs Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Ponatinib Drugs Sales by Country
  2. 10.1.1 South America Ponatinib Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Ponatinib Drugs Sales by Country (2021-2026)
  4. 10.1.3 South America Ponatinib Drugs Sales Forecast by Country (2027-2032)
  5. 10.2 South America Ponatinib Drugs Market Size by Country
  6. 10.2.1 South America Ponatinib Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Ponatinib Drugs Market Size by Country (2021-2026)
  8. 10.2.3 South America Ponatinib Drugs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Ponatinib Drugs Sales by Country
  2. 11.1.1 Middle East and Africa Ponatinib Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Ponatinib Drugs Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Ponatinib Drugs Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Ponatinib Drugs Market Size by Country
  6. 11.2.1 Middle East and Africa Ponatinib Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Ponatinib Drugs Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Ponatinib Drugs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Ponatinib Drugs Value Chain Analysis
  2. 12.1.1 Ponatinib Drugs Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Ponatinib Drugs Production Mode & Process
  7. 12.2 Ponatinib Drugs Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Ponatinib Drugs Distributors
  10. 12.2.3 Ponatinib Drugs Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst